High Prevalence of Isolates with Reduced Glycopeptide Susceptibility in Persistent or Recurrent Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus

Reduced susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates is considered a risk factor for failure of glycopeptide therapy. We compared the prevalences of MRSA isolates with reduced glycopeptide susceptibility in patients with versus without persi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Uçkay, Ilker, Bernard, Louis, Buzzi, Marta, Harbarth, Stephan, François, Patrice, Huggler, Elzbieta, Ferry, Tristan, Schrenzel, Jacques, Renzoni, Adriana, Vaudaux, Pierre, Lew, Daniel P.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2012
Materias:
Clinical Therapeutics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3294919/
https://ncbi.nlm.nih.gov/pubmed/22155824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05808-11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares